PPL Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
PPL Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2022-12-31 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-09-30 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2013-03-31 | 2012-03-31 | 2010-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | ||||||||||||||||||||||||||
net income | 183,000,000 | 414,000,000 | 177,000,000 | 214,000,000 | 190,000,000 | 307,000,000 | 113,000,000 | 230,000,000 | 190,000,000 | 273,000,000 | 134,000,000 | 207,000,000 | 19,000,000 | -1,840,000,000 | 281,000,000 | 475,000,000 | 441,000,000 | 466,000,000 | 515,000,000 | 452,000,000 | 355,000,000 | 292,000,000 | 403,000,000 | 413,000 | 545,000,000 | 253,000 |
adjustments to reconcile net income to net cash from operating activities | ||||||||||||||||||||||||||
depreciation | 324,000,000 | 322,000,000 | 322,000,000 | 322,000,000 | 319,000,000 | 316,000,000 | 314,000,000 | 314,000,000 | 309,000,000 | 271,000,000 | 272,000,000 | 274,000,000 | 269,000,000 | 267,000,000 | 323,000,000 | 306,000,000 | 300,000,000 | 284,000,000 | 273,000,000 | 269,000,000 | 257,000,000 | 246,000,000 | 242,000,000 | 129,000 | ||
amortization | 29,000,000 | 20,000,000 | 17,000,000 | 14,000,000 | 23,000,000 | 24,000,000 | 20,000,000 | 22,000,000 | 22,000,000 | 7,000,000 | 9,000,000 | -10,000,000 | 29,000,000 | 11,000,000 | 18,000,000 | 29,000,000 | 9,000,000 | 22,000,000 | 13,000,000 | 21,000,000 | 27,000,000 | 22,000,000 | 23,000,000 | 87,000 | ||
defined benefit plans - income | -14,000,000 | -16,000,000 | -17,000,000 | -20,000,000 | -15,000,000 | -19,000,000 | 4,000,000 | -50,000,000 | ||||||||||||||||||
deferred income taxes and investment tax credits | 66,000,000 | 38,000,000 | 49,000,000 | 33,000,000 | 42,000,000 | 72,000,000 | 180,000,000 | 35,000,000 | 124,000,000 | 39,000,000 | 36,000,000 | 22,000,000 | -21,000,000 | 50,000,000 | 186,000,000 | 103,000,000 | 65,000,000 | 89,000,000 | 112,000,000 | 59,000,000 | 83,000,000 | 40,000,000 | 161,000,000 | -116,000 | ||
other | -10,000,000 | 13,000,000 | -30,000,000 | 3,000,000 | 7,000,000 | 3,000,000 | -6,000,000 | -48,000,000 | 3,000,000 | -4,000,000 | 13,000,000 | 16,000,000 | -4,000,000 | -5,000,000 | -8,000,000 | -8,000,000 | -4,000,000 | -3,000,000 | -6,000,000 | -3,000,000 | -3,000,000 | -4,000,000 | -1,000,000 | -5,000 | ||
change in current assets and current liabilities | ||||||||||||||||||||||||||
accounts receivable | 186,000,000 | -277,000,000 | -5,000,000 | 97,000,000 | 237,000,000 | -75,000,000 | -133,000,000 | -36,000,000 | -73,000,000 | -38,000,000 | -60,000,000 | -50,000,000 | 35,000,000 | 79,000,000 | -57,000,000 | 117,000,000 | -71,000,000 | -1,000,000 | 69,000,000 | -43,000,000 | -48,000 | |||||
accounts payable | -47,000,000 | -120,000,000 | 195,000,000 | -69,000,000 | 54,000,000 | -221,000,000 | 57,000,000 | 80,000,000 | 238,000,000 | 4,000,000 | 56,000,000 | -6,000,000 | 16,000,000 | -42,000,000 | 63,000,000 | -14,000,000 | -8,000,000 | -94,000,000 | -54,000,000 | -36,000,000 | -1,000,000 | -8,000,000 | -84,000,000 | -5,000 | ||
unbilled revenues | -45,000,000 | 108,000,000 | -166,000,000 | 35,000,000 | 17,000,000 | 57,000,000 | -96,000,000 | -9,000,000 | -239,000,000 | 28,000,000 | 14,000,000 | -23,000,000 | 76,000,000 | 19,000,000 | -12,000,000 | 22,000,000 | 48,000,000 | 33,000,000 | 58,000,000 | 11,000,000 | 18,000,000 | 52,000,000 | ||||
fuel, materials and supplies | -24,000,000 | 37,000,000 | 7,000,000 | -13,000,000 | -29,000,000 | 33,000,000 | -17,000,000 | -13,000,000 | -19,000,000 | 42,000,000 | 41,000,000 | -14,000,000 | -10,000,000 | -12,000,000 | 31,000,000 | -11,000,000 | 43,000,000 | -7,000,000 | -2,000,000 | 44,000,000 | ||||||
prepayments | 31,000,000 | -87,000,000 | 41,000,000 | 32,000,000 | 1,000,000 | -108,000,000 | 46,000,000 | -75,000,000 | 29,000,000 | 14,000,000 | -76,000,000 | 22,000,000 | 26,000,000 | 7,000,000 | -86,000,000 | 13,000,000 | -73,000,000 | 29,000,000 | 44,000,000 | -110,000,000 | 108,000 | |||||
taxes payable | 0 | 40,000,000 | -19,000,000 | 13,000,000 | 26,000,000 | -47,000,000 | 21,000,000 | 16,000,000 | -66,000,000 | -4,000,000 | -48,000,000 | -117,000,000 | 6,000,000 | 22,000,000 | 33,000,000 | -6,000,000 | -21,000,000 | |||||||||
regulatory assets and liabilities | -15,000,000 | 79,000,000 | -14,000,000 | 20,000,000 | -13,000,000 | -61,000,000 | -10,000,000 | 30,000,000 | 39,000,000 | -41,000,000 | 2,000,000 | 11,000,000 | 10,000,000 | 29,000,000 | 3,000,000 | 10,000,000 | -47,000,000 | -25,000,000 | -22,000,000 | 64,000,000 | ||||||
accrued interest | -72,000,000 | 67,000,000 | -71,000,000 | 83,000,000 | -69,000,000 | 90,000,000 | -96,000,000 | 79,000,000 | 57,000,000 | 69,000,000 | 141,000,000 | 137,000,000 | -111,000,000 | 48,000,000 | 126,000,000 | |||||||||||
other operating activities | ||||||||||||||||||||||||||
defined benefit plans - funding | -2,000,000 | -5,000,000 | 0 | -3,000,000 | -2,000,000 | -5,000,000 | 1,000,000 | -7,000,000 | -4,000,000 | -3,000,000 | -12,000,000 | -5,000,000 | -3,000,000 | -33,000,000 | -71,000,000 | -74,000,000 | -80,000,000 | -127,000,000 | -56,000,000 | -150,000,000 | -6,000,000 | -32,000,000 | -520,000,000 | -26,000 | ||
other assets | -27,000,000 | -50,000,000 | -30,000,000 | -6,000,000 | -59,000,000 | -1,000,000 | -11,000,000 | 39,000,000 | -49,000,000 | -18,000,000 | -6,000,000 | -35,000,000 | 4,000,000 | -74,000,000 | -34,000,000 | -35,000,000 | 31,000,000 | -20,000,000 | -37,000,000 | -30,000,000 | 5,000,000 | -6,000,000 | 5,000,000 | -58,000 | ||
other liabilities | 11,000,000 | 10,000,000 | -14,000,000 | 44,000,000 | -4,000,000 | 16,000,000 | -305,000,000 | -23,000,000 | -31,000,000 | 6,000,000 | -11,000,000 | -5,000,000 | -7,000,000 | 31,000,000 | 6,000,000 | -26,000,000 | -20,000,000 | -10,000,000 | 69,000,000 | -12,000,000 | 6,000,000 | -15,000,000 | 4,000,000 | 0 | ||
net cash from operating activities | 602,000,000 | 513,000,000 | 511,000,000 | 781,000,000 | 766,000,000 | 282,000,000 | 110,000,000 | 806,000,000 | 219,000,000 | 502,000,000 | 292,000,000 | 457,000,000 | 858,000,000 | 663,000,000 | 948,000,000 | 818,000,000 | 596,000,000 | 474,000,000 | 759,000,000 | 566,000,000 | 964,000,000 | 655,000,000 | 135,000,000 | 1,124,000 | ||
capex | -930,000,000 | -396,000,000 | -860,000,000 | -679,000,000 | -670,000,000 | -343,000,000 | -649,000,000 | -651,000,000 | -640,000,000 | -191,000,000 | -513,000,000 | -491,000,000 | -498,000,000 | -242,000,000 | -772,000,000 | -723,000,000 | -745,000,000 | -407,000,000 | -777,000,000 | -437,000,000 | -779,000,000 | -696,000,000 | -441,000,000 | -356,000 | ||
free cash flows | -328,000,000 | 117,000,000 | -349,000,000 | 102,000,000 | 96,000,000 | -61,000,000 | -539,000,000 | 155,000,000 | -421,000,000 | 311,000,000 | -221,000,000 | -34,000,000 | 360,000,000 | 421,000,000 | 176,000,000 | 95,000,000 | -149,000,000 | 67,000,000 | -18,000,000 | 129,000,000 | 185,000,000 | -41,000,000 | -306,000,000 | 768,000 | ||
cash flows from investing activities | ||||||||||||||||||||||||||
expenditures for property, plant and equipment | -930,000,000 | -793,000,000 | -860,000,000 | -679,000,000 | -670,000,000 | -596,000,000 | -649,000,000 | -651,000,000 | -640,000,000 | -427,000,000 | -513,000,000 | -491,000,000 | -498,000,000 | -471,000,000 | -772,000,000 | -723,000,000 | -745,000,000 | -729,000,000 | -777,000,000 | -750,000,000 | -779,000,000 | -696,000,000 | -677,000,000 | -828,000 | -682,000,000 | -356,000 |
other investing activities | 0 | 10,000,000 | -14,000,000 | -4,000,000 | 0 | 5,000,000 | 5,000,000 | 8,000,000 | 12,000,000 | -1,000,000 | -14,000,000 | -7,000,000 | -1,000,000 | -6,000,000 | 6,000,000 | -16,000,000 | 5,000,000 | -61,000,000 | 4,000,000 | 7,000,000 | 5,000,000 | 1,000,000 | -15,000 | -19,000,000 | 1,000 | |
net cash from investing activities | -930,000,000 | -783,000,000 | -874,000,000 | -683,000,000 | -670,000,000 | -591,000,000 | -644,000,000 | -643,000,000 | -468,000,000 | -427,000,000 | -514,000,000 | -505,000,000 | 9,711,000,000 | -735,000,000 | -785,000,000 | -715,000,000 | -757,000,000 | -722,000,000 | -896,000,000 | -753,000,000 | -782,000,000 | -705,000,000 | -677,000,000 | -382,000 | ||
cash flows from financing activities | ||||||||||||||||||||||||||
issuance of long-term debt | 0 | 746,000,000 | 0 | 1,148,000,000 | 125,000,000 | 0 | 0 | 0 | 0 | 0 | 696,000,000 | 440,000,000 | 144,000,000 | 494,000,000 | 530,000,000 | 64,000,000 | 450,000 | 3,000 | ||||||||
payment of common stock dividends | -202,000,000 | -190,000,000 | -190,000,000 | -190,000,000 | -190,000,000 | -177,000,000 | -178,000,000 | -178,000,000 | -167,000,000 | -306,000,000 | -318,000,000 | -321,000,000 | -320,000,000 | -320,000,000 | -320,000,000 | -299,000,000 | -298,000,000 | -296,000,000 | -285,000,000 | -273,000,000 | -271,000,000 | -271,000,000 | -258,000,000 | -210,000 | -203,000,000 | -134,000 |
net increase in short-term debt | 508,000,000 | 475,000,000 | -701,000,000 | 705,000,000 | 44,000,000 | 475,000,000 | 916,000,000 | 69,000,000 | 0 | -1,547,000,000 | 752,000,000 | 525,000,000 | -240,000,000 | -218,000,000 | 424,000,000 | 419,000,000 | 369,000,000 | -285,000,000 | -190,000,000 | 744,000,000 | 416,000 | 93,000,000 | ||||
other financing activities | 0 | -14,000,000 | 6,000,000 | -6,000,000 | -1,000,000 | -22,000,000 | 1,000,000 | -2,000,000 | -5,000,000 | -7,000,000 | -6,000,000 | -5,000,000 | -14,000,000 | -10,000,000 | 3,000,000 | -6,000,000 | -10,000,000 | -8,000,000 | -7,000,000 | -9,000,000 | -9,000,000 | -9,000,000 | -16,000,000 | -30,000,000 | -5,000 | |
net cash from financing activities | 306,000,000 | 271,000,000 | 119,000,000 | 161,000,000 | -93,000,000 | 248,000,000 | 562,000,000 | -136,000,000 | 302,000,000 | 603,000,000 | -974,000,000 | -2,814,000,000 | -3,531,000,000 | -71,000,000 | -712,000,000 | 165,000,000 | 56,000,000 | 142,000,000 | 364,000,000 | 331,000,000 | 27,000,000 | 104,000,000 | 607,000,000 | -409,000 | ||
net decrease in cash, cash equivalents and restricted cash | 3,000,000 | -61,000,000 | 27,000,000 | |||||||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of period | 0 | 339,000,000 | 0 | 0 | 0 | 382,000,000 | 0 | 0 | 0 | 3,572,000,000 | 0 | 0 | 0 | 443,000,000 | 0 | 0 | 0 | 643,000,000 | 0 | 511,000,000 | ||||||
cash, cash equivalents and restricted cash at end of period | -22,000,000 | 340,000,000 | -244,000,000 | 259,000,000 | 3,000,000 | 321,000,000 | 28,000,000 | 27,000,000 | 53,000,000 | 4,250,000,000 | -1,196,000,000 | -2,862,000,000 | 7,208,000,000 | 422,000,000 | -532,000,000 | 262,000,000 | -112,000,000 | 540,000,000 | 222,000,000 | 653,000,000 | ||||||
supplemental disclosures of cash flow information | ||||||||||||||||||||||||||
significant non-cash transactions: | ||||||||||||||||||||||||||
accrued expenditures for property, plant and equipment at june 30, | ||||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash | 1,000,000 | -244,000,000 | 53,000,000 | 678,000,000 | -1,196,000,000 | -2,862,000,000 | 7,208,000,000 | -21,000,000 | -532,000,000 | 262,000,000 | -112,000,000 | -103,000,000 | 222,000,000 | 142,000,000 | ||||||||||||
accrued expenditures for property, plant and equipment at march 31, | 397,000,000 | 253,000,000 | 236,000,000 | 229,000,000 | 322,000,000 | 313,000,000 | 236,000,000 | |||||||||||||||||||
income from discontinued operations | ||||||||||||||||||||||||||
income from continuing operations | 273,000,000 | 142,000,000 | 209,000,000 | -536,000,000 | 203,000,000 | |||||||||||||||||||||
defined benefit plans - expense | -24,000,000 | -26,000,000 | -19,000,000 | 21,000 | ||||||||||||||||||||||
stock compensation expense | ||||||||||||||||||||||||||
loss on sale of safari holdings | ||||||||||||||||||||||||||
proceeds from transfer of excess benefit plan funds | ||||||||||||||||||||||||||
proceeds from sale of safari holdings, net of cash divested | ||||||||||||||||||||||||||
acquisition of narragansett electric, net of cash acquired | 14,000,000 | |||||||||||||||||||||||||
retirement of long-term debt | -91,000,000 | 0 | -1,000,000 | 0 | -2,227,000,000 | 0 | 0 | 0 | ||||||||||||||||||
cash paid (received) during the period for: | ||||||||||||||||||||||||||
interest - net of amount capitalized | ||||||||||||||||||||||||||
income taxes - net | ||||||||||||||||||||||||||
accrued expenditures for property, plant and equipment at december 31, | ||||||||||||||||||||||||||
net decrease in short-term debt | -389,000,000 | -285,000 | ||||||||||||||||||||||||
accrued expenditures for property, plant and equipment at september 30, | ||||||||||||||||||||||||||
loss | 8,000,000 | 2,000,000 | -555,000,000 | 2,043,000,000 | ||||||||||||||||||||||
impairment of solar panels | 0 | 0 | ||||||||||||||||||||||||
loss on extinguishment of debt | 0 | 73,000,000 | ||||||||||||||||||||||||
net cash from operating activities - continuing operations | 219,000,000 | 502,000,000 | 292,000,000 | 457,000,000 | 399,000,000 | 396,000,000 | ||||||||||||||||||||
net cash from operating activities - discontinued operations | 0 | 0 | 459,000,000 | 267,000,000 | ||||||||||||||||||||||
proceeds from sale of u.k. utility business, net of cash divested | ||||||||||||||||||||||||||
net cash from investing activities - continuing operations | -468,000,000 | -427,000,000 | -514,000,000 | -505,000,000 | 10,055,000,000 | -472,000,000 | ||||||||||||||||||||
net cash from investing activities - discontinued operations | 0 | 0 | -344,000,000 | -263,000,000 | ||||||||||||||||||||||
purchase of treasury stock | -721,000,000 | |||||||||||||||||||||||||
retirement of term loan | 0 | 0 | 0 | -300,000,000 | ||||||||||||||||||||||
retirement of commercial paper | 0 | 0 | 0 | -73,000,000 | ||||||||||||||||||||||
net cash from financing activities - continuing operations | 302,000,000 | 603,000,000 | -974,000,000 | -2,814,000,000 | -3,611,000,000 | 55,000,000 | ||||||||||||||||||||
net cash from financing activities - discontinued operations | 0 | 0 | -285,000,000 | -126,000,000 | ||||||||||||||||||||||
contributions from discontinued operations | ||||||||||||||||||||||||||
effect of exchange rates on cash, cash equivalents and restricted cash included in discontinued operations | 0 | 0 | 0 | 8,000,000 | ||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash included in discontinued operations | 0 | 0 | 170,000,000 | 114,000,000 | ||||||||||||||||||||||
cash paid during the period for: | ||||||||||||||||||||||||||
stock-based compensation expense | 11,000,000 | 6,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 14,000,000 | 1,000,000 | 15,000,000 | 8,000,000 | 3,000,000 | 19,000,000 | |||||||||||||||
impairment of assets held for sale | ||||||||||||||||||||||||||
issuance of term loan | 0 | |||||||||||||||||||||||||
issuance of commercial paper | ||||||||||||||||||||||||||
income | ||||||||||||||||||||||||||
proceeds from sale of discontinued operations, net of cash divested | 0 | 0 | ||||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash included in discontinued operations | ||||||||||||||||||||||||||
issuance of common stock | 4,000,000 | 1,000,000 | -1,000,000 | 14,000,000 | 13,000,000 | 22,000,000 | 47,000,000 | 100,000,000 | 98,000,000 | 104,000,000 | 73,000,000 | 20,000 | 16,000,000 | |||||||||||||
proceeds from project financing | -2,000,000 | 16,000,000 | 0 | 5,000,000 | 56,000,000 | |||||||||||||||||||||
contributions (to) from discontinued operations | 0 | |||||||||||||||||||||||||
unrealized (gains) losses on derivatives, and other hedging activities | 73,000,000 | 59,000,000 | 100,000,000 | 35,000,000 | ||||||||||||||||||||||
other current liabilities | -103,000,000 | 8,000,000 | -9,000,000 | -13,000,000 | -72,000,000 | 73,000,000 | -120,000,000 | -1,000,000 | 8,000,000 | -60,000,000 | ||||||||||||||||
purchase of investments | 0 | 0 | -55,000,000 | |||||||||||||||||||||||
proceeds from the sale of investments | -7,000,000 | 2,000,000 | 4,000,000 | 57,000,000 | ||||||||||||||||||||||
effect of exchange rates on cash, cash equivalents and restricted cash | 17,000,000 | -6,000,000 | -7,000,000 | 3,000,000 | -5,000,000 | -2,000,000 | ||||||||||||||||||||
accrued expenditures for intangible assets at september 30, | ||||||||||||||||||||||||||
accrued expenditures for intangible assets at june 30, | ||||||||||||||||||||||||||
unrealized gains on derivatives, and other hedging activities | ||||||||||||||||||||||||||
defined benefit plans - | -69,000,000 | -66,000,000 | -51,000,000 | -50,000,000 | ||||||||||||||||||||||
unrealized losses on derivatives, and other hedging activities | 53,000,000 | 85,000,000 | 251,000 | |||||||||||||||||||||||
accrued expenditures for intangible assets at march 31, | 64,000,000 | 65,000,000 | 62,000,000 | |||||||||||||||||||||||
purchase of available-for-sale securities | ||||||||||||||||||||||||||
expenditures for intangible assets | -7,000,000 | -10,000,000 | -12,000,000 | -3,000,000 | -22,000 | |||||||||||||||||||||
settlement of cross-currency swaps | ||||||||||||||||||||||||||
effect of exchange rates on cash and cash equivalents | 0 | 4,000,000 | 3,000,000 | -14,000 | 8,000,000 | 15,000 | ||||||||||||||||||||
net increase in cash and cash equivalents | 209,000,000 | 58,000,000 | 68,000,000 | -48,000 | -99,000,000 | 348,000 | ||||||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 341,000,000 | 901,000 | 1,202,000,000 | 0 | ||||||||||||||||||||
cash and cash equivalents at end of period | 209,000,000 | 58,000,000 | 409,000,000 | 853,000 | 1,103,000,000 | 348,000 | ||||||||||||||||||||
counterparty collateral | 71,000 | |||||||||||||||||||||||||
net increase in restricted cash and cash equivalents | 2,000,000 | -52,000 | -22,000,000 | |||||||||||||||||||||||
proceeds from the receipt of grants | ||||||||||||||||||||||||||
repurchase of common stock | ||||||||||||||||||||||||||
debt issuance and credit facility costs | -18,000 | |||||||||||||||||||||||||
contract adjustment payments | -24,000 | |||||||||||||||||||||||||
proceeds from the sale of other investments | 16,000,000 | |||||||||||||||||||||||||
the accompanying notes to condensed financial statements are an integral part of the financial statements. | ||||||||||||||||||||||||||
proceeds from the sale of certain non-core generation facilities | ||||||||||||||||||||||||||
ironwood acquisition, net of cash acquired | ||||||||||||||||||||||||||
acquisition of wpd midlands | ||||||||||||||||||||||||||
redemption of preference stock of a subsidiary | ||||||||||||||||||||||||||
gains related to the extinguishment of notes | ||||||||||||||||||||||||||
impairment of assets | 104,000 | |||||||||||||||||||||||||
benefit from montana hydroelectric litigation | 3,000 | |||||||||||||||||||||||||
unbilled revenue | 151,000 | |||||||||||||||||||||||||
price risk management assets and liabilities | -14,000 | |||||||||||||||||||||||||
proceeds from the sale of the long island generation business | 0 | |||||||||||||||||||||||||
purchases of nuclear plant decommissioning trust investments | -18,000 | |||||||||||||||||||||||||
proceeds from the sale of nuclear plant decommissioning trust investments | 15,000 | |||||||||||||||||||||||||
net decrease in restricted cash and cash equivalents | -2,000 | |||||||||||||||||||||||||
issuance of equity, net of issuance costs | 15,000 | |||||||||||||||||||||||||
redemption of preferred stock of a subsidiary | 0 | |||||||||||||||||||||||||
debt issuance costs | -3,000 |
We provide you with 20 years of cash flow statements for PPL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PPL stock. Explore the full financial landscape of PPL stock with our expertly curated income statements.
The information provided in this report about PPL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.